Literature DB >> 19416582

Local recurrence of osteosarcoma after 17 years.

M J Welck1, P D Gikas, P Pearce, R Bhumbra, T W R Briggs, S Cannon.   

Abstract

The recurrence of osteosarcoma is rare. Local recurrence occurs in 4-10% of patients following effective treatment. So far, recurrences as late as 15 years have been reported in the literature. We report a unique case of local recurrence of intramedullary osteosarcoma 17 years from initial diagnosis and treatment. Regular long-term follow-up of patients with this diagnosis is crucial to ensure early detection and treatment of potential recurrences.

Entities:  

Mesh：

Year:  2009        PMID： 19416582      PMCID： PMC2749398          DOI： 10.1308/147870809X400967

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN： 0035-8843            Impact factor:   1.891


  4 in total

1.  Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols.

Authors:  Stefan S Bielack; Beate Kempf-Bielack; Günter Delling; G Ulrich Exner; Silke Flege; Knut Helmke; Rainer Kotz; Mechthild Salzer-Kuntschik; Matthias Werner; Winfried Winkelmann; Andreas Zoubek; Heribert Jürgens; Kurt Winkler
Journal:  J Clin Oncol       Date:  2002-02-01       Impact factor: 44.544

2.  Local recurrence of parosteal osteosarcoma adjacent to a prosthesis after 20 years: a case report.

Authors:  T W Lau; J W K Wong; D K H Yip; E P Chien; T W H Shek; L L S Wong
Journal:  J Orthop Surg (Hong Kong)       Date:  2004-12       Impact factor: 1.118

3.  Survival data for 648 patients with osteosarcoma treated at one institution.

Authors:  Henry J Mankin; Francis J Hornicek; Andrew E Rosenberg; David C Harmon; Mark C Gebhardt
Journal:  Clin Orthop Relat Res       Date:  2004-12       Impact factor: 4.176

4.  Late relapse of osteosarcoma: implications for follow-up and screening.

Authors:  Sandra J Strauss; Anne McTiernan; Jeremy S Whelan
Journal:  Pediatr Blood Cancer       Date:  2004-11       Impact factor: 3.167
  4 in total
  3 in total

1.  Regenerative therapy with mesenchymal stem cells at the site of malignant primary bone tumour resection: what are the risks of early or late local recurrence?

Authors:  Philippe Hernigou; Charles Henri Flouzat Lachaniette; Jerome Delambre; Nathalie Chevallier; Helene Rouard
Journal:  Int Orthop       Date:  2014-06-07       Impact factor: 3.075

2.  Late post-operative recurrent osteosarcoma: Three case reports with a review of the literature.

Authors:  Xiuchun Yu; Sujia Wu; Xuquan Wang; Ming Xu; Songfeng Xu; Ye Yuan
Journal:  Oncol Lett       Date:  2013-04-29       Impact factor: 2.967

Review 3.  Very late relapse of high-grade osteosarcoma: A case report and review of the literature.

Authors:  Yoichi Kaneuchi; Michiyuki Hakozaki; Hitoshi Yamada; Osamu Hasegawa; Shoki Yamada; Yuka Oka; Kazuo Watanabe; Shinichi Konno
Journal:  Medicine (Baltimore)       Date:  2020-07-17       Impact factor: 1.817
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.